NIRVF (Nirvana Life Sciences) Total Inventories: $0.00 Mil (As of Jan. 2026)


What is Nirvana Life Sciences Total Inventories?

Nirvana Life Sciences NIRVF Total Inventories is $0.00 Mil as of Jan. 2026. The stock has 3 warning signs investors should review.

Nirvana Life Sciences's total inventories for the quarter that ended in Jan. 2026 was $0.00 Mil. Nirvana Life Sciences's average total inventories from the quarter that ended in Oct. 2025 to the quarter that ended in Jan. 2026 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Nirvana Life Sciences's Net-Net Working Capital per share for the quarter that ended in Jan. 2026 was $-0.02.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nirvana Life Sciences  (OTCPK:NIRVF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Nirvana Life Sciences's Net-Net Working Capital Per Share for the quarter that ended in Jan. 2026 is

Net-Net Working Capital Per Share (Q: Jan. 2026 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.001+0.75 * 0+0.5 * 0-0.53
-0--0.004)/22.823
=-0.02

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nirvana Life Sciences's Days Inventory for the three months ended in Jan. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Jan. 2026 )/Cost of Goods Sold (Q: Jan. 2026 )*Days in Period
=0/0*365 / 4
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nirvana Life Sciences's Inventory Turnover for the quarter that ended in Jan. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jan. 2026 ) / Average Total Inventories (Q: Jan. 2026 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nirvana Life Sciences's Inventory to Revenue for the quarter that ended in Jan. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jan. 2026 ) / Revenue (Q: Jan. 2026 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Nirvana Life Sciences Total Inventories Related Terms

Nirvana Life Sciences Total Inventories Historical Data

* Premium members only.

The historical data trend for Nirvana Life Sciences's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences Total Inventories Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23 Apr24 Apr25
Total Inventories
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nirvana Life Sciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nirvana Life Sciences Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $0.00 Mil mean?
Nirvana Life Sciences (NIRVF) has a Total Inventories of $0.00 Mil as of Jan. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Nirvana Life Sciences and its competitors.
Is Nirvana Life Sciences' Total Inventories too high?
Nirvana Life Sciences' current Total Inventories is $0.00 Mil.
How does Nirvana Life Sciences' Total Inventories compare to VRTX and REGN?
Nirvana Life Sciences' Total Inventories of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Nirvana Life Sciences and its competitors. Nirvana Life Sciences's current Total Inventories is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirvana Life Sciences stock overvalued right now?
Nirvana Life Sciences (NIRVF) has a current Total Inventories of $0.00 Mil. The current Total Inventories is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Nirvana Life Sciences (NIRVF), the current Total Inventories is $0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nirvana Life Sciences Business Description

Other Exchanges NIRV.X:Canada
Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.